COMT, Oestrogen, and the Hormonal Mood Cycle: Why Your PMS May Be a Gene Problem

Many women experience mood changes, irritability, anxiety, and emotional dysregulation in the days before their period. For some, these changes are mild and manageable. For others, they are severe enough to affect relationships, work, and quality of life. The standard explanation — hormonal fluctuation — is accurate but incomplete. The deeper question is why hormonal fluctuation affects some women so much more severely than others.

For many women, the answer lies in the intersection of oestrogen metabolism, dopamine clearance, and the COMT gene variant.

Oestrogen and Histamine: The Feedback Loop

Oestrogen stimulates mast cells to release histamine. Histamine in turn stimulates further oestrogen production. This creates a self-amplifying feedback loop that peaks around ovulation — when oestrogen surges — producing the histamine-mediated symptoms that many women experience mid-cycle: headaches, bloating, mood instability, skin reactions, and sleep disruption.

COMT — catechol-O-methyltransferase — is responsible for clearing catechol oestrogens (the metabolic intermediates produced during oestrogen breakdown) as well as dopamine and noradrenaline. Women with slow COMT variants clear oestrogen metabolites slowly, allowing them to accumulate. These accumulated metabolites have biological effects of their own — they are weakly oestrogenic and pro-inflammatory, and they compete with dopamine for COMT's methylation activity.

The Dopamine-Oestrogen Competition

COMT uses SAM to methylate both oestrogen metabolites and catecholamines. When oestrogen levels are high — as they are in the mid-luteal phase — COMT is partly occupied with oestrogen clearance. This reduces its capacity to clear dopamine and noradrenaline, producing catecholamine accumulation. In women with already-slow COMT, this pre-menstrual dopamine excess produces the irritability, emotional flooding, rumination, and hypersensitivity that characterise severe PMS and PMDD.

The MTHFR Connection

The methylation cycle is the source of SAM — the methyl donor that COMT requires for oestrogen and catecholamine clearance. When MTHFR is impaired and SAM production is reduced, COMT function is compromised regardless of its genetic speed. Women with both MTHFR and slow COMT variants face a compound challenge: reduced SAM supply from impaired methylation, and increased SAM demand from slow catecholamine and oestrogen clearance. The result is a particularly severe hormonal mood response that is both biologically driven and nutritionally modifiable.

Supporting the COMT-Oestrogen Cycle

Magnesium is a direct COMT cofactor — ensuring adequate magnesium is a foundational step. Methylfolate, methylcobalamin, and P5P B6 restore SAM production capacity. DIM (diindolylmethane), from cruciferous vegetables, supports healthy oestrogen metabolism through Phase I liver detoxification. Calcium D-glucarate supports Phase II oestrogen conjugation and excretion. Reducing alcohol and processed foods reduces the oestrogen and histamine burden on the methylation system.

NeuroThrive™ products are food supplements and are not intended to diagnose, treat, or cure any medical condition. If you have severe PMS or PMDD, please consult your GP.